- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 28
- Grants since 2016
- 3 213
Grants received
2017–2022 · research · R01
Lineages and pathophysiology of clonal histiocytic disorders
Frederic Geissmann · Kettering University · funded by National Institutes of Health
2017–2020 · fellowship · F32
Development of a Novel Peptide Platform for Targeted PET Imaging and Radiotherapy of Breast Cancer
Lukas Michael Carter · Kettering University · funded by National Institutes of Health
2017–2021 · research · R01
Phase2 trial of MEK162 & imatinib combined therapy in GIST, IND119794(09/20/2013)
Ping Chi · Kettering University · funded by U.S. Food and Drug Administration
2017–2019 · fellowship · F99
Role of the tumor microenvironment in promoting drug resistance in castration resistant prostate cancer
Zeda Zhang · Kettering University · funded by National Institutes of Health
2017–2027 · research · R01
Ferroptosis, Cellular Metabolism, and Cancer
Xuejun Jiang · Kettering University · funded by National Institutes of Health
2017–2024 · research · R35
Isolation, characterization and translational development of glioma stem cells
Luis Fernando Parada · Kettering University · funded by National Institutes of Health
2017–2020 · fellowship · F32
Development of a Novel Peptide Platform for Targeted PET Imaging and Radiotherapy of Breast Cancer
Lukas Michael Carter · Kettering University · funded by National Institutes of Health
2017–2020 · fellowship · F32
Mechanisms of epithelial remodeling in the mouse embryo
Marissa Lynn Gredler · Kettering University · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D
Christina S Leslie · Kettering University · funded by National Institutes of Health
2017–2027 · research · R01
Development of the resident macrophage lineage in mouse and human
Frederic Geissmann · Kettering University · funded by National Institutes of Health
2017–2023 · research · R01
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
Yu Chen · Kettering University · funded by National Institutes of Health
2017–2020 · fellowship · F32
Development of a Novel Peptide Platform for Targeted PET Imaging and Radiotherapy of Breast Cancer
Lukas Michael Carter · Kettering University · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
Vinod P Balachandran · Kettering University · funded by National Institutes of Health
2017–2022 · cooperative agreement · U24
The cBioPortal for Cancer Genomics
Ethan Cerami · Kettering University · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Dissecting anti-ceramide scFv vascular mitigation of the Radiation GI Syndrome
Richard N Kolesnick · Kettering University · funded by National Institutes of Health
2017–2022 · research · R35
Investigating long noncoding RNAs as regulators of the p53 pathway functions.
Adam Schmitt · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Programming age in iPS models of Alzheimer's disease
Lorenz P. Studer · Kettering University · funded by National Institutes of Health
2017–2022 · cooperative agreement · U54
The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center
Charles L. Sawyers · Kettering University · funded by National Institutes of Health
2017–2030 · research · R35
Synergistic role of signaling and epigenetics in leukemic transformation
Ross L Levine · Kettering University · funded by National Institutes of Health
2017–2020 · cooperative agreement · UG3
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries
Olusegun Isaac Alatise · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
A Single-Molecule Study of Translation Initiation in S. cerevisiae
Xiaohui Qu · Kettering University · funded by National Institutes of Health
2017–2023 · cooperative agreement · U01
Quantitative imaging tools to derive DW-MRI oncological biomarkers
Amita Dave · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Protein and proteolytic activity biomarkers of early stage pancreatic cancer
Paul Tempst · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Smart and self-reporting clinical nano carriers for drug delivery
Jan Grimm · Kettering University · funded by National Institutes of Health
2017–2022 · career development · K08
Inflammatory monocytes and host control of cryptococcosis
Lena J Heung · Kettering University · funded by National Institutes of Health
2017–2021 · research · R01
Sizing and Scaling in Functional Muscle Cells
Mary K Baylies · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Regulation of Nfil3 in innate lymphocyte-mediated host immunity
Joseph Chai-Yuen Sun · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Structure and function of genome plasticity in human cancer
Alex Kentsis · Kettering University · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center
Charles L. Sawyers · Kettering University · funded by National Institutes of Health
2017–2018 · fellowship · F32
Mechanistic studies on the functional role of the HOTAIR long noncoding RNA in the ubiquitination pathway
Dimitrios Zattas · Kettering University · funded by National Institutes of Health
2017–2019 · cooperative agreement · U54
The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center
Charles L. Sawyers · Kettering University · funded by National Institutes of Health
2017–2023 · research · R35
Synergistic role of signaling and epigenetics in leukemic transformation
Ross L Levine · Kettering University · funded by National Institutes of Health
2017–2023 · research · R01
Orchestrating intestinal immunity through microbiota-CX3CR1+ cell interactions
Gretchen E Diehl · Kettering University · funded by National Institutes of Health
2017–2022 · cooperative agreement · U24
Coordinating center for the NCI small cell lung cancer research consortium
Charles M. Rudin · Kettering University · funded by National Institutes of Health
2017–2019 · grant · Standard Grant
D3SC: EAGER: Collaborative Research: A probabilistic framework for automated force field parameterization from experimental datasets
John Chodera · Kettering University · funded by National Science Foundation
2017–2022 · research · R01
Programming age in iPS models of Alzheimer's disease
Lorenz P. Studer · Kettering University · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Preclinical development of a DLL3-targeted theranostic for small cell lung cancer
John Thomas Poirier · Kettering University · funded by National Institutes of Health
2017–2022 · research · R01
Imaging tumor and T cell responses to metabolic and immune modulation therapy
Jason Arthur Koutcher · Kettering University · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
Vinod P Balachandran · Kettering University · funded by National Institutes of Health
2017–2025 · research · R01
Mechanisms of Lipid Droplet Formation
Robert V Farese · Kettering University · funded by National Institutes of Health
